Literature DB >> 27965312

Hyponatraemia-induced rhabdomyolysis complicated by anuric acute kidney injury: a renal replacement conundrum.

Paul Secombe1,2, Chris Milne2.   

Abstract

Hyponatraemia-induced rhabdomyolysis is a rare, but reported phenomenon, particularly in patients with chronic schizophrenia on depot antipsychotics prone to psychogenic polydipsia. To the best of our knowledge, there are no reported cases of hyponatraemia-induced rhabdomyolysis complicated by oligo-anuric acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). The initiation of CRRT is complicated in severe hyponatraemia, predominantly due to the need to avoid rapid changes in tonicity associated with rapid changes in sodium. We report a case of severe hyponatraemia (104 mmol/L) complicated by oligo-anuric rhabdomyolysis-induced AKI and our management of the renal prescription. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Year:  2016        PMID： 27965312      PMCID： PMC5174836          DOI： 10.1136/bcr-2016-218198

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  19 in total

Review 1.  Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions.

Authors:  Reinaldo DiPolo; Luis Beaugé
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

2.  Case report: exercise-associated hyponatremia with rhabdomyolysis during endurance exercise.

Authors:  Christopher Ellis; Jennifer Cuthill; Tamara Hew-Butler; Sajid Melvin George; Mitchell H Rosner
Journal:  Phys Sportsmed       Date:  2009-04       Impact factor: 2.241

3.  Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid.

Authors:  Lenar Yessayan; Jerry Yee; Stan Frinak; Balazs Szamosfalvi
Journal:  Am J Kidney Dis       Date:  2014-05-03       Impact factor: 8.860

4.  Sodium-reduced continuous venovenous hemodiafiltration (CVVHDF) for the prevention of central pontine myelinolysis (CPM) in hyponatremic patients scheduled for orthotopic liver transplantation.

Authors:  Marcus R Lenk; Michael Kaspar
Journal:  J Clin Anesth       Date:  2012-05-31       Impact factor: 9.452

5.  Psychogenic polydipsia with hyponatremia: report of eleven cases.

Authors:  R E Cronin
Journal:  Am J Kidney Dis       Date:  1987-05       Impact factor: 8.860

6.  Rhabdomyolysis associated with polydipsia induced hyponatraemia.

Authors:  Michael Bennett; Gerry Fitzpatrick; Maria Donnelly
Journal:  BMJ Case Rep       Date:  2011-10-04

7.  Proof of concept: hypovolemic hyponatremia may precede and augment creatine kinase elevations during an ultramarathon.

Authors:  Ross S Cairns; Tamara Hew-Butler
Journal:  Eur J Appl Physiol       Date:  2016-01-08       Impact factor: 3.078

8.  Successful treatment of extreme hyponatremia in an anuric patient using continuous venovenous hemodialysis.

Authors:  Olof Viktorsdottir; Olafur Skuli Indridason; Runolfur Palsson
Journal:  Blood Purif       Date:  2013-12-20       Impact factor: 2.614

9.  Rhabdomyolysis and exercise-associated hyponatremia in ultra-bikers and ultra-runners.

Authors:  Daniela Chlíbková; Thomas Rosemann; Ivana Tomášková; Jan Novotný; Alena Žákovská; Tomáš Uher; Beat Knechtle
Journal:  J Int Soc Sports Nutr       Date:  2015-06-25       Impact factor: 5.150

10.  Recurrent rhabdomyolysis secondary to hyponatremia in a patient with primary psychogenic polydipsia.

Authors:  Diana Tavares Aguiar; Catarina Monteiro; Paula Coutinho
Journal:  Rev Bras Ter Intensiva       Date:  2015-03-01
View more
  2 in total

1.  Serum creatine kinase levels are not associated with an increased need for continuous renal replacement therapy in patients with acute kidney injury following rhabdomyolysis.

Authors:  Luniu Xiao; Xiao Ran; Yanxia Zhong; Yue Le; Shusheng Li
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

2.  A suspected case of hyponatraemia induced rhabdomyolysis: a case report.

Authors:  Edward Reakes; Douglas Drak; David Gracey
Journal:  BMC Nephrol       Date:  2022-05-11       Impact factor: 2.585
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.